Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Long-term use of lamivudine for treating chronic hepatitis B in the State of Mato Grosso].

Revista da Sociedade Brasileira de Medicina Tropical - 1 Jan 2000

Souto Francisco José Dutra, Pirajá Ana Carolina da Silva, da Silva Graciana Soares, Bottecchia Marcelle, Gomes Selma Andrade

Abstract excerpt

To assess the results from lamivudine treatment (100 mg or 150 mg) for chronic hepatitis B, 34 patients were followed at a clinic in Cuiabá, Mato Grosso, Central Brazil. Among them, 21 (62%) had liver cirrhosis and 24 (70%) were HBeAg-positive. The viral genotype was determined for 18 patients, a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Aspartate Aminotransferases
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Lamivudine

Share to Liver Cirrhosis

Share to Viral Load

Source

Identifiers

PMID: 17486248
DOI: 10.1590/s0037-86822007000100004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17486248-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Long-term use of lamivudine for treating chronic hepatitis B in the State of Mato Grosso].PMID 17486248Read ↗

[Treatment of chronic viral hepatitis B with lamivudine].Semantic proximity Read ↗

Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil.Semantic proximity Read ↗

[Relationship between B virus hepatitis genotypes and therapeutic efficacy in early treatment for chronic hepatitis B by using lamivudine].Semantic proximity Read ↗

[Lamivudine therapy for chronic hepatitis B].Semantic proximity Read ↗

[Lamivudine treatment for hepatitis B].Semantic proximity Read ↗

Efficacy and tolerability of long-term therapy using high lamivudine doses for the treatment of chronic hepatitis B.Semantic proximity Read ↗

[Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients].Semantic proximity Read ↗

[The influence of HBV genotypes on the therapeutic effects of lamivudine in chronic hepatitis B patients].Semantic proximity Read ↗

Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes.Semantic proximity Read ↗

Lamivudine as initial treatment for chronic hepatitis B in the United States.Semantic proximity Read ↗

Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B.Semantic proximity Read ↗

Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.